Your browser doesn't support javascript.
loading
Line-selective macrophage activation with an anti-CD40 antibody drives a hemophagocytic syndrome in mice.
Ingoglia, Giada; Yalamanoglu, Ayla; Pfefferlé, Marc; Dubach, Irina L; Schaer, Christian A; Valkova, Kristyna; Hansen, Kerstin; Schulthess, Nadja; Humar, Rok; Schaer, Dominik J; Vallelian, Florence.
Affiliation
  • Ingoglia G; Division of Internal Medicine and.
  • Yalamanoglu A; Division of Internal Medicine and.
  • Pfefferlé M; Division of Internal Medicine and.
  • Dubach IL; Division of Internal Medicine and.
  • Schaer CA; Institute of Anesthesiology, University of Zurich, Zurich, Switzerland.
  • Valkova K; Division of Internal Medicine and.
  • Hansen K; Division of Internal Medicine and.
  • Schulthess N; Division of Internal Medicine and.
  • Humar R; Division of Internal Medicine and.
  • Schaer DJ; Division of Internal Medicine and.
  • Vallelian F; Division of Internal Medicine and.
Blood Adv ; 4(12): 2751-2761, 2020 06 23.
Article in En | MEDLINE | ID: mdl-32559293

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Lymphohistiocytosis, Hemophagocytic / Macrophage Activation Syndrome Type of study: Prognostic_studies Limits: Animals Language: En Journal: Blood Adv Year: 2020 Document type: Article

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Lymphohistiocytosis, Hemophagocytic / Macrophage Activation Syndrome Type of study: Prognostic_studies Limits: Animals Language: En Journal: Blood Adv Year: 2020 Document type: Article